Skip to main content
. 2019 Jun 19;12(4):369–384. doi: 10.1159/000499978

Fig. 1.

Fig. 1

Current use of potentially weight-inducing drugs (Table 1) by subjects with obesity in the overall group and stratified by obesity class (i.e., class I, BMI = 30.00–34.99; class II, BMI = 35.00–39.99; and class III, BMI ≥40.00). Between-group analyses, with class I as the reference group, were performed with logistic regression analyses with adjustments for sex and age. * p < 0.05. HT, hypertension; PPI, proton pump inhibitor; ref, reference.